ABSTRACT
INTRODUCTION
Tumour diseases are currently one of the most frequently occurring diseases resulting in high mortality rates [11] . Tumours are considered genetic diseases as their origin and development is associated essentially with changes at the genetic or epigenetic levels in proto-oncogenes and tumour-suppressor genes [15] .
Lymphomas are a heterogeneous group of tumour diseases of the immune system blood cells of the lymphoid line. On the basis of pathological findings, lymphomas are divided to two basic categories: non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL). In humans, lymphomas account for 3-4 % of all tumour diseases [9] . However, in dogs they belong among the most frequent types of tumours [14] . The frequency of disease occurrence and similar carcinogenic load on humans and dogs (Canis lupus familiaris) in their common environment are advantageous with respect to investigation of individual types of tumours [5] .
The most frequent changes described in relation to lymphomas in humans are translocations in genes MYC, BCL2, BCL6, short mutations/deletions in genes TNFAIP3, PRDM1, EZH2, or amplification of gene JAK2 [1] . Mutations in proto-oncogenes C-KIT, FLT3 and NRAS have been described in association with a number of haematological malignancies including lymphomas. The frequency of these mutations in canine lymphomas has not been specified [13] .
The aim of our study was to detect potential genetic changes in selected sections of DNA (exons and/or introns) of the three above mentioned proto-oncogenes.
MATERIALS AND METHODS

DNA isolation
Samples of genomic DNA were isolated from dog lymphomas by a column-based method employing QIAGEN DNeasy® Blood and Tissue Kit (Qiagen, Venlo, the Netherlands). Sample 1 was isolated from the lymph node tissue of a 10 years old female mongrel. Sample 2 was obtained from the spleen of a 12 years old Bernese Mountain Dog.
The reference DNA sample was isolated from the blood of a healthy Jack Russell Terrier. was used as a positive control.
Selection of primers, PCR and electrophoresis
Primers were selected by means of software Primer3Plus on the basis of the reference DNA sequences obtained from the database Ensembl. Table 1 
RESULTS
From the C-KIT gene we obtained sufficient amounts of amplified sections of exons 8 and 17 from both samples (Fig. 1a) . In sample 1 (mongrel) we detected a nucleotide exchange -transition G/A ( From the FLT3 gene we obtained from both samples sufficient amount of amplified sections that included exons 14-15 and 20 and the surrounding intron regions (Fig. 2a) .
In sample 1 (mongrel) we detected several changes in intron regions close to exons 14 and 15 (Fig. 2d) ; in 34 nt position in front of exon 14 -transversion A/C (Fig. 2b) , and in 263 nt position, between exons 14 and 15 -transition G/A (Fig. 2c ).
When comparing sample 1 with the reference sequence ( Fig. 3a) , we detected a transition C/T (Fig. 3b) in the intron region behind exon 20, in 242 nt position. In the sec- has already been observed in dogs [13] and does not affect the significance of the codon. Our results agree with those of G i a n t i n et al. [3] according to which the occurrence of mutations in canine lymphoma C-KIT gene is rare.
In relation to the damage in the C-KIT gene, cases have been described of acute myeloid leukaemia [13] and adipose cell tumours [6] . L o n d o n et al. [6] reported the occurrence of intragene tandem duplications in exons 11 and 12 associated with tumour diseases of mastocytes. In dogs with acute myeloid leukaemia diagnosis, U s h e r et al. [13] found silent mutations in exon 8, codon 425, and a number of point mutations resulting in changes in AMK sequence in the exon 17. In the aggressive canine T-cell lymphomas, G i a n t i n et al. [3] observed increased expression of C-KIT oncogene in comparison with less aggressive forms of the disease, while in B-cell lymphomas expression of this protein was reduced. In our study we observed no change in genetic code in comparison with reference sequence, which is in agreement with observations of M a y r et al. [7] who reported that activation of proto-oncogene NRAS in canine lymphoma is rare.
CONCLUSIONS
The results of our study allowed us to conclude that proto-oncogenes C-KIT and NRAS probably did not play an important role in the process of lymphomagenesis in dogs.
We identified a silent mutation caused by nucleotide ex- 
